EUVIMEDEUVIMED entdecken
Crossref

Sex steroid hormones, gonadotropins and risk of testicular germ cell tumors: results from the STEED study

Zeni Wu, Aika Wojt, Britton Trabert iD, Andrea A Almeida iD, Nader Rifai iD, Frank Z Stanczyk, Barry I Graubard iD, Katherine A McGlynn iD

JNCI: Journal of the National Cancer Institute · 2026

DOI: 10.1093/jnci/djaf376 ↗

Kurz gefasst

Fachartikel in der Zeitschrift JNCI: Journal of the National Cancer Institute, 2026. Verfasst von Zeni Wu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, R…. Hauptthemen laut MEDLINE: Testicular Neoplasms, Neoplasms, Germ Cell and Embryonal, Luteinizing Hormone, Gonadal Steroid Hormones. Gefördert von: Intramural Research Program of the National Cancer Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Testicular germ cell tumors (TGCT) are thought to be endocrine-related. The hypothesis, however, has not been thoroughly investigated. As a result, pre-diagnostic serum samples from the U.S. Servicemen’s Testicular Tumor Environmental and Endocrine Determinants (STEED) were analyzed to assess the relationship of hormones and gonadotropins to TGCT risk.

Methods

The study included 517 men who subsequently developed TGCT and 790 comparison men. The hormones/gonadotropins examined included testosterone, estradiol, sex-hormone binding globulin (SHBG), 5α-androstane-3α,17β-diol glucuronide (3α-diol G), follicle-stimulating hormone (FSH) and luteinizing hormone (LH). Adjusted odds ratios (OR) and 95% confidence intervals (CI) were estimated using logistic regression. Analyses stratified by histology (seminoma, nonseminoma) were also conducted.

Results

Compared to men in the middle quintile of LH concentrations, men with the lowest concentrations had an increased risk of TGCT (OR 1.88, 95% CI 1.31-2.70), as did men with FSH concentrations in the lowest (OR 1.77, 95% CI 1.21-2.60) and highest quintiles (OR 2.20, 95% CI 1.53-3.17). An increased risk of seminoma was found with both low and high LH, and high FSH, while an increased risk of nonseminoma was found with low LH, and both low and high FSH. Decreased levels of 3α-diol G were associated with increased risk of seminoma (OR 1.65, 95%CI 1.02-2.67).

Conclusion

These results suggest that gonadotropin disruption may be a critical event in the development of TGCT. Further examination of upstream and downstream metabolites in the hormone pathways may help elucidate the underlying mechanism that distinguishes men who develop TGCT from men who do not.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Testicular NeoplasmsNeoplasms, Germ Cell and EmbryonalLuteinizing HormoneGonadal Steroid HormonesGonadotropinsHumansMaleAdultFollicle Stimulating HormoneSeminomaTestosteroneSex Hormone-Binding GlobulinOdds RatioRisk FactorsEstradiolUnited StatesLogistic ModelsMiddle AgedAndrostane-3,17-diolRisk AssessmentCase-Control Studies

Substanzen

Follicle Stimulating HormoneLuteinizing HormoneTestosteroneSex Hormone-Binding GlobulinEstradiolAndrostane-3,17-diolGonadal Steroid Hormonesandrostane-3,17-diol glucuronideGonadotropins

Autor:innen und Institutionen

  • Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, US Department of Health and Human Services, Rockville, MD, United States.
  • School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
  • Department of Obstetrics and Gynecology, University of Utah, and Huntsman Cancer Institute at the University of Utah, Salt Lake City, UT, United States.
  • Department of Surgery, Center for Prostate Disease Research, Murtha Cancer Center Research Program, Uniformed Services University of the Health Sciences, Bethesda, MD, United States.
  • Henry M. Jackson Foundation for the Advancement of Military Medicine, Bethesda, MD, United States.
  • Department of Laboratory Medicine, Boston Children's Hospital, Boston, MA, United States.

ORCID-Profile: Britton Trabert, Andrea A Almeida, Nader Rifai, Barry I Graubard, Katherine A McGlynn

Förderung

  • Intramural Research Program of the National Cancer Institute

Zitieren

APA

Wu, Z., Wojt, A., Trabert, B., Almeida, A. A., Rifai, N., Stanczyk, F. Z., Graubard, B. I., & McGlynn, K. A. (2026). Sex steroid hormones, gonadotropins and risk of testicular germ cell tumors: results from the STEED study. JNCI: Journal of the National Cancer Institute. https://doi.org/10.1093/jnci/djaf376

Vancouver

Wu Z, Wojt A, Trabert B, Almeida AA, Rifai N, Stanczyk FZ, et al. Sex steroid hormones, gonadotropins and risk of testicular germ cell tumors: results from the STEED study. JNCI: Journal of the National Cancer Institute. 2026. doi:10.1093/jnci/djaf376

BibTeX
@article{Wu2026,
  author = {Wu, Zeni and Wojt, Aika and Trabert, Britton and Almeida, Andrea A and Rifai, Nader and Stanczyk, Frank Z and Graubard, Barry I and McGlynn, Katherine A},
  title = {Sex steroid hormones, gonadotropins and risk of testicular germ cell tumors: results from the STEED study},
  journal = {JNCI: Journal of the National Cancer Institute},
  year = {2026},
  doi = {10.1093/jnci/djaf376}
}
Kostenlos starten →